| 发明名称 |
Vitamin K and essential fatty acids |
| 摘要 |
Use of a source of vitamin K and a source of at least one essential fatty acid (EFA) in the manufacture of an oral medicine for the treatment of disorders selected from: - premenstrual or menstrual disorders; - skin disorders such as dermatitis; and - bone or calcium disorders, including osteoporosis. The concentration of vitamin K is not less than 1,000 mug/100g. |
| 申请公布号 |
NZ523138(A) |
申请公布日期 |
2004.09.24 |
| 申请号 |
NZ20010523138 |
申请日期 |
2001.06.20 |
| 申请人 |
PABAY INVESTMENTS LIMITED |
发明人 |
HORROBIN, DAVID FREDERICK |
| 分类号 |
A23L1/30;A23L1/302;A61K31/122;A61K31/20;A61K31/202;A61P1/04;A61P3/04;A61P3/06;A61P3/10;A61P5/24;A61P9/00;A61P11/06;A61P13/12;A61P15/00;A61P19/02;A61P19/10;A61P25/00;A61P25/18;A61P29/00 |
主分类号 |
A23L1/30 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
